Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Parasite voltage-gated calcium channels are multisubunit protein complexes found in helminth and protozoan parasites that regulate calcium influx in response to membrane depolarization. The channels consist of a pore-forming alpha-1 subunit containing four homologous domains with six transmembrane segments each, along with modulatory auxiliary subunits including beta, alpha-2-delta, and gamma subunits[1][3][6]. In platyhelminths such as Schistosoma mansoni and Taenia solium, these channels are distinguished by the presence of variant calcium channel beta subunits (CavβVar), which represent a platyhelminth-specific gene family not found in vertebrates[1][3]. These variant beta subunits lack conserved protein kinase C phosphorylation sites present in conventional beta subunits and confer unique pharmacological properties, particularly sensitivity to praziquantel[3][5]. The Schistosoma mansoni genome contains approximately four genes encoding high voltage-activated calcium channel subunits, but notably lacks genes for low voltage-activated calcium channel subunits[6]. In trypanosomatids like Trypanosoma brucei, the calcium channel (TbCav) is a single subunit channel localized in the flagellar plasma membrane and is essential for proliferation of both bloodstream and procyclic forms of the parasite[2]. The Trypanosoma cruzi calcium channel shares some characteristics with human L-type voltage-gated calcium channels, including inhibition by nifedipine and activation by Bay K8644, but differs in that it appears not to be voltage-dependent and is uniquely activated by sphingosine[4]. This sphingosine-stimulated plasma membrane calcium channel represents a distinctive feature of trypanosomatid parasites. These channels play critical roles in calcium-dependent processes including muscle contraction, neurotransmission, secretion, and cell proliferation in parasites. The structural and functional differences between parasite and host calcium channels make them attractive therapeutic targets with potential for selective drug action.
Channel blockade leading to disruption of calcium homeostasis. Increased calcium influx causing tetanic muscular contraction (praziquantel). Inhibition of calcium entry reducing parasite proliferation. Modulation by variant beta subunits conferring drug sensitivity. Activation leading to calcium overload and paralysis.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parasite voltage-gated calcium channel (VGCC (general); specific examples include TbCav (Trypanosoma brucei), SmCav (Schistosoma mansoni)).